Bioequivalence Study of Cephalexin Suspension 125

Clinical trial NCT01767532 · COMPLETED

Trial details

NCT number: NCT01767532
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Respiratory Tract

Start date: 2011-01-30
Primary completion: 2011-02-08
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.